Astec LifeSciences Limited (BSE: ASTEC.BO) Stock Competitors & Peer Comparison
See ASTEC.BO's competitors and their performance on the BSE and across the wider stock market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ASTEC.BO and its BSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ASTEC.BO | ₹730.90 | -2.25% | 15.8B | -23.74 | -₹30.10 | N/A |
| COROMANDEL.BO | ₹1,702.45 | -2.47% | 493.8B | 25.28 | ₹66.35 | +0.65% |
| COROMANDEL.NS | ₹1,703.40 | -2.41% | 492.9B | 26.91 | ₹62.20 | +0.65% |
| FACT.BO | ₹728.85 | -2.50% | 464.9B | -439.34 | -₹1.64 | +0.05% |
| FACT.NS | ₹729.40 | -2.35% | 464.4B | -438.88 | -₹1.64 | +0.05% |
| UPL.BO | ₹489.60 | -1.09% | 407.2B | 20.88 | ₹23.18 | +1.23% |
| UPL.NS | ₹488.45 | -1.32% | 406.1B | 20.75 | ₹23.18 | +1.23% |
| PIIND.BO | ₹2,120.00 | -4.28% | 320B | 27.85 | ₹76.28 | +0.71% |
| PIIND.NS | ₹2,118.20 | -4.15% | 318.6B | 27.58 | ₹76.14 | +0.71% |
| SUMICHEM.BO | ₹417.75 | -1.19% | 207.2B | 34.73 | ₹11.85 | +0.31% |
Stock Comparison
Coromandel International Limited (BSE: COROMANDEL.BO)
ASTEC.BO vs COROMANDEL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, COROMANDEL.BO has a market cap of 493.8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while COROMANDEL.BO trades at ₹1,702.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas COROMANDEL.BO's P/E ratio is 25.28. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to COROMANDEL.BO's ROE of +0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to COROMANDEL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check COROMANDEL.BO's competition here
Coromandel International Limited (NSE: COROMANDEL.NS)
ASTEC.BO vs COROMANDEL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, COROMANDEL.NS has a market cap of 492.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while COROMANDEL.NS trades at ₹1,703.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas COROMANDEL.NS's P/E ratio is 26.91. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to COROMANDEL.NS's ROE of +0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to COROMANDEL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check COROMANDEL.NS's competition here
The Fertilisers And Chemicals Travancore Limited (BSE: FACT.BO)
ASTEC.BO vs FACT.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, FACT.BO has a market cap of 464.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while FACT.BO trades at ₹728.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas FACT.BO's P/E ratio is -439.34. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to FACT.BO's ROE of -0.08%. Regarding short-term risk, ASTEC.BO is more volatile compared to FACT.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check FACT.BO's competition here
The Fertilisers And Chemicals Travancore Limited (NSE: FACT.NS)
ASTEC.BO vs FACT.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, FACT.NS has a market cap of 464.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while FACT.NS trades at ₹729.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas FACT.NS's P/E ratio is -438.88. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to FACT.NS's ROE of -0.08%. Regarding short-term risk, ASTEC.BO is more volatile compared to FACT.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check FACT.NS's competition here
UPL Limited (BSE: UPL.BO)
ASTEC.BO vs UPL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, UPL.BO has a market cap of 407.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while UPL.BO trades at ₹489.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas UPL.BO's P/E ratio is 20.88. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to UPL.BO's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to UPL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check UPL.BO's competition here
UPL Limited (NSE: UPL.NS)
ASTEC.BO vs UPL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, UPL.NS has a market cap of 406.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while UPL.NS trades at ₹488.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas UPL.NS's P/E ratio is 20.75. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to UPL.NS's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to UPL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check UPL.NS's competition here
PI Industries Limited (BSE: PIIND.BO)
ASTEC.BO vs PIIND.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, PIIND.BO has a market cap of 320B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while PIIND.BO trades at ₹2,120.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas PIIND.BO's P/E ratio is 27.85. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to PIIND.BO's ROE of +0.10%. Regarding short-term risk, ASTEC.BO is more volatile compared to PIIND.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check PIIND.BO's competition here
PI Industries Limited (NSE: PIIND.NS)
ASTEC.BO vs PIIND.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, PIIND.NS has a market cap of 318.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while PIIND.NS trades at ₹2,118.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas PIIND.NS's P/E ratio is 27.58. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to PIIND.NS's ROE of +0.10%. Regarding short-term risk, ASTEC.BO is more volatile compared to PIIND.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check PIIND.NS's competition here
Sumitomo Chemical India Limited (BSE: SUMICHEM.BO)
ASTEC.BO vs SUMICHEM.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SUMICHEM.BO has a market cap of 207.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SUMICHEM.BO trades at ₹417.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SUMICHEM.BO's P/E ratio is 34.73. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SUMICHEM.BO's ROE of +0.18%. Regarding short-term risk, ASTEC.BO is more volatile compared to SUMICHEM.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SUMICHEM.BO's competition here
Sumitomo Chemical India Limited (NSE: SUMICHEM.NS)
ASTEC.BO vs SUMICHEM.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SUMICHEM.NS has a market cap of 205.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SUMICHEM.NS trades at ₹417.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SUMICHEM.NS's P/E ratio is 34.63. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SUMICHEM.NS's ROE of +0.18%. Regarding short-term risk, ASTEC.BO is more volatile compared to SUMICHEM.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SUMICHEM.NS's competition here
Atul Ltd (BSE: ATUL7.BO)
ASTEC.BO vs ATUL7.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, ATUL7.BO has a market cap of 179B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while ATUL7.BO trades at ₹7,100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas ATUL7.BO's P/E ratio is N/A. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to ATUL7.BO's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to ATUL7.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check ATUL7.BO's competition here
Paradeep Phosphates Limited (NSE: PARADEEP.NS)
ASTEC.BO vs PARADEEP.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, PARADEEP.NS has a market cap of 156.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while PARADEEP.NS trades at ₹146.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas PARADEEP.NS's P/E ratio is 13.15. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to PARADEEP.NS's ROE of +0.16%. Regarding short-term risk, ASTEC.BO is more volatile compared to PARADEEP.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check PARADEEP.NS's competition here
Bayer CropScience Limited (BSE: BAYERCROP.BO)
ASTEC.BO vs BAYERCROP.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BAYERCROP.BO has a market cap of 152.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BAYERCROP.BO trades at ₹3,495.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BAYERCROP.BO's P/E ratio is 20.80. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BAYERCROP.BO's ROE of +0.24%. Regarding short-term risk, ASTEC.BO is less volatile compared to BAYERCROP.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check BAYERCROP.BO's competition here
Bayer CropScience Limited (NSE: BAYERCROP.NS)
ASTEC.BO vs BAYERCROP.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BAYERCROP.NS has a market cap of 152B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BAYERCROP.NS trades at ₹3,492.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BAYERCROP.NS's P/E ratio is 20.75. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BAYERCROP.NS's ROE of +0.24%. Regarding short-term risk, ASTEC.BO is less volatile compared to BAYERCROP.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check BAYERCROP.NS's competition here
Chambal Fertilisers and Chemicals Limited (BSE: CHAMBLFERT.BO)
ASTEC.BO vs CHAMBLFERT.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, CHAMBLFERT.BO has a market cap of 151.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while CHAMBLFERT.BO trades at ₹374.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas CHAMBLFERT.BO's P/E ratio is 7.79. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to CHAMBLFERT.BO's ROE of +0.20%. Regarding short-term risk, ASTEC.BO is more volatile compared to CHAMBLFERT.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check CHAMBLFERT.BO's competition here
Chambal Fertilisers and Chemicals Limited (NSE: CHAMBLFERT.NS)
ASTEC.BO vs CHAMBLFERT.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, CHAMBLFERT.NS has a market cap of 151.7B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while CHAMBLFERT.NS trades at ₹374.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas CHAMBLFERT.NS's P/E ratio is 7.78. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to CHAMBLFERT.NS's ROE of +0.20%. Regarding short-term risk, ASTEC.BO is more volatile compared to CHAMBLFERT.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check CHAMBLFERT.NS's competition here
Paradeep Phosphates Limited (BSE: PARADEEP.BO)
ASTEC.BO vs PARADEEP.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, PARADEEP.BO has a market cap of 123.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while PARADEEP.BO trades at ₹146.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas PARADEEP.BO's P/E ratio is 12.73. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to PARADEEP.BO's ROE of +0.16%. Regarding short-term risk, ASTEC.BO is less volatile compared to PARADEEP.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check PARADEEP.BO's competition here
E.I.D.- Parry (India) Limited (NSE: EIDPARRY.NS)
ASTEC.BO vs EIDPARRY.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, EIDPARRY.NS has a market cap of 120.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while EIDPARRY.NS trades at ₹688.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas EIDPARRY.NS's P/E ratio is -68.82. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to EIDPARRY.NS's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to EIDPARRY.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check EIDPARRY.NS's competition here
E.I.D.- Parry (India) Limited (BSE: EIDPARRY.BO)
ASTEC.BO vs EIDPARRY.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, EIDPARRY.BO has a market cap of 120.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while EIDPARRY.BO trades at ₹688.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas EIDPARRY.BO's P/E ratio is 34.07. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to EIDPARRY.BO's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to EIDPARRY.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check EIDPARRY.BO's competition here
Madhya Bharat Agro Products Limited (NSE: MBAPL.NS)
ASTEC.BO vs MBAPL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MBAPL.NS has a market cap of 71.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MBAPL.NS trades at ₹165.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MBAPL.NS's P/E ratio is 47.73. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MBAPL.NS's ROE of +0.31%. Regarding short-term risk, ASTEC.BO is more volatile compared to MBAPL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check MBAPL.NS's competition here
Sharda Cropchem Limited (NSE: SHARDACROP.NS)
ASTEC.BO vs SHARDACROP.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SHARDACROP.NS has a market cap of 65.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SHARDACROP.NS trades at ₹723.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SHARDACROP.NS's P/E ratio is 10.46. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SHARDACROP.NS's ROE of +0.22%. Regarding short-term risk, ASTEC.BO is more volatile compared to SHARDACROP.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SHARDACROP.NS's competition here
Sharda Cropchem Limited (BSE: SHARDACROP.BO)
ASTEC.BO vs SHARDACROP.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SHARDACROP.BO has a market cap of 65.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SHARDACROP.BO trades at ₹724.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SHARDACROP.BO's P/E ratio is 10.44. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SHARDACROP.BO's ROE of +0.22%. Regarding short-term risk, ASTEC.BO is more volatile compared to SHARDACROP.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SHARDACROP.BO's competition here
Gujarat State Fertilizers & Chemicals Limited (NSE: GSFC.NS)
ASTEC.BO vs GSFC.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, GSFC.NS has a market cap of 58.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while GSFC.NS trades at ₹147.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas GSFC.NS's P/E ratio is 8.73. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to GSFC.NS's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to GSFC.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check GSFC.NS's competition here
Krishana Phoschem Limited (NSE: KRISHANA.NS)
ASTEC.BO vs KRISHANA.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, KRISHANA.NS has a market cap of 58.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while KRISHANA.NS trades at ₹197.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas KRISHANA.NS's P/E ratio is 32.37. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to KRISHANA.NS's ROE of +0.39%. Regarding short-term risk, ASTEC.BO is less volatile compared to KRISHANA.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check KRISHANA.NS's competition here
Gujarat State Fertilizers & Chemicals Limited (BSE: GSFC.BO)
ASTEC.BO vs GSFC.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, GSFC.BO has a market cap of 58.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while GSFC.BO trades at ₹147.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas GSFC.BO's P/E ratio is 8.70. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to GSFC.BO's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to GSFC.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check GSFC.BO's competition here
Rashtriya Chemicals and Fertilizers Limited (BSE: RCF.BO)
ASTEC.BO vs RCF.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, RCF.BO has a market cap of 57.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while RCF.BO trades at ₹104.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas RCF.BO's P/E ratio is 13.37. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to RCF.BO's ROE of +0.09%. Regarding short-term risk, ASTEC.BO is more volatile compared to RCF.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check RCF.BO's competition here
Rashtriya Chemicals and Fertilizers Limited (NSE: RCF.NS)
ASTEC.BO vs RCF.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, RCF.NS has a market cap of 57.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while RCF.NS trades at ₹104.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas RCF.NS's P/E ratio is 12.83. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to RCF.NS's ROE of +0.09%. Regarding short-term risk, ASTEC.BO is more volatile compared to RCF.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check RCF.NS's competition here
Dhanuka Agritech Limited (BSE: DHANUKA.BO)
ASTEC.BO vs DHANUKA.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, DHANUKA.BO has a market cap of 40.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while DHANUKA.BO trades at ₹860.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas DHANUKA.BO's P/E ratio is 14.98. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to DHANUKA.BO's ROE of +0.17%. Regarding short-term risk, ASTEC.BO is less volatile compared to DHANUKA.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check DHANUKA.BO's competition here
Dhanuka Agritech Limited (NSE: DHANUKA.NS)
ASTEC.BO vs DHANUKA.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, DHANUKA.NS has a market cap of 39.8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while DHANUKA.NS trades at ₹860.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas DHANUKA.NS's P/E ratio is 15.01. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to DHANUKA.NS's ROE of +0.17%. Regarding short-term risk, ASTEC.BO is less volatile compared to DHANUKA.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check DHANUKA.NS's competition here
Rallis India Limited (BSE: RALLIS.BO)
ASTEC.BO vs RALLIS.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, RALLIS.BO has a market cap of 38.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while RALLIS.BO trades at ₹198.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas RALLIS.BO's P/E ratio is 18.77. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to RALLIS.BO's ROE of +0.10%. Regarding short-term risk, ASTEC.BO is more volatile compared to RALLIS.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check RALLIS.BO's competition here
Rallis India Limited (NSE: RALLIS.NS)
ASTEC.BO vs RALLIS.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, RALLIS.NS has a market cap of 38.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while RALLIS.NS trades at ₹198.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas RALLIS.NS's P/E ratio is 16.38. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to RALLIS.NS's ROE of +0.10%. Regarding short-term risk, ASTEC.BO is more volatile compared to RALLIS.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check RALLIS.NS's competition here
Mangalore Chemicals & Fertilizers Limited (NSE: MANGCHEFER.NS)
ASTEC.BO vs MANGCHEFER.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MANGCHEFER.NS has a market cap of 36.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MANGCHEFER.NS trades at ₹308.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MANGCHEFER.NS's P/E ratio is 22.67. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MANGCHEFER.NS's ROE of +0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to MANGCHEFER.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check MANGCHEFER.NS's competition here
Mangalore Chemicals & Fertilizers Limited (BSE: MANGCHEFER.BO)
ASTEC.BO vs MANGCHEFER.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MANGCHEFER.BO has a market cap of 36.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MANGCHEFER.BO trades at ₹308.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MANGCHEFER.BO's P/E ratio is 22.63. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MANGCHEFER.BO's ROE of +0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to MANGCHEFER.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check MANGCHEFER.BO's competition here
Kaveri Seed Company Limited (BSE: KSCL.BO)
ASTEC.BO vs KSCL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, KSCL.BO has a market cap of 34.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while KSCL.BO trades at ₹676.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas KSCL.BO's P/E ratio is 13.87. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to KSCL.BO's ROE of +0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to KSCL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check KSCL.BO's competition here
Kaveri Seed Company Limited (NSE: KSCL.NS)
ASTEC.BO vs KSCL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, KSCL.NS has a market cap of 34.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while KSCL.NS trades at ₹676.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas KSCL.NS's P/E ratio is 13.85. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to KSCL.NS's ROE of +0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to KSCL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check KSCL.NS's competition here
BN Holdings Ltd. (BSE: BNHOLDINGS.BO)
ASTEC.BO vs BNHOLDINGS.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BNHOLDINGS.BO has a market cap of 34.8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BNHOLDINGS.BO trades at ₹355.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BNHOLDINGS.BO's P/E ratio is 26.71. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BNHOLDINGS.BO's ROE of +0.09%. Regarding short-term risk, ASTEC.BO is less volatile compared to BNHOLDINGS.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check BNHOLDINGS.BO's competition here
NACL Industries Limited (BSE: NACLIND.BO)
ASTEC.BO vs NACLIND.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NACLIND.BO has a market cap of 30.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NACLIND.BO trades at ₹129.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NACLIND.BO's P/E ratio is 258.92. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NACLIND.BO's ROE of +0.02%. Regarding short-term risk, ASTEC.BO is more volatile compared to NACLIND.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NACLIND.BO's competition here
NACL Industries Limited (NSE: NACLIND.NS)
ASTEC.BO vs NACLIND.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NACLIND.NS has a market cap of 30.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NACLIND.NS trades at ₹129.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NACLIND.NS's P/E ratio is 258.72. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NACLIND.NS's ROE of +0.02%. Regarding short-term risk, ASTEC.BO is more volatile compared to NACLIND.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NACLIND.NS's competition here
National Fertilizers Limited (NSE: NFL.NS)
ASTEC.BO vs NFL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NFL.NS has a market cap of 30.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NFL.NS trades at ₹61.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NFL.NS's P/E ratio is 8.26. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NFL.NS's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to NFL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NFL.NS's competition here
National Fertilizers Limited (BSE: NFL.BO)
ASTEC.BO vs NFL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NFL.BO has a market cap of 30.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NFL.BO trades at ₹61.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NFL.BO's P/E ratio is 8.26. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NFL.BO's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to NFL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NFL.BO's competition here
Jubilant Agri and Consumer Products Limited (NSE: JUBLCPL.NS)
ASTEC.BO vs JUBLCPL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, JUBLCPL.NS has a market cap of 29.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while JUBLCPL.NS trades at ₹1,906.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas JUBLCPL.NS's P/E ratio is 23.17. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to JUBLCPL.NS's ROE of +0.30%. Regarding short-term risk, ASTEC.BO is more volatile compared to JUBLCPL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check JUBLCPL.NS's competition here
Jubilant Agri and Consumer Products Limited (BSE: JUBLCPL.BO)
ASTEC.BO vs JUBLCPL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, JUBLCPL.BO has a market cap of 29.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while JUBLCPL.BO trades at ₹1,921.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas JUBLCPL.BO's P/E ratio is 22.42. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to JUBLCPL.BO's ROE of +0.30%. Regarding short-term risk, ASTEC.BO is more volatile compared to JUBLCPL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check JUBLCPL.BO's competition here
Bhagiradha Chemicals & Industries Limited (BSE: BHAGCHEM.BO)
ASTEC.BO vs BHAGCHEM.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BHAGCHEM.BO has a market cap of 28.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BHAGCHEM.BO trades at ₹222.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BHAGCHEM.BO's P/E ratio is 105.11. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BHAGCHEM.BO's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to BHAGCHEM.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BHAGCHEM.BO's competition here
Bhagiradha Chemicals & Industries Limited (NSE: BHAGCHEM.NS)
ASTEC.BO vs BHAGCHEM.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BHAGCHEM.NS has a market cap of 28.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BHAGCHEM.NS trades at ₹222.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BHAGCHEM.NS's P/E ratio is 105.00. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BHAGCHEM.NS's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to BHAGCHEM.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BHAGCHEM.NS's competition here
Insecticides (India) Limited (BSE: INSECTICID.BO)
ASTEC.BO vs INSECTICID.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, INSECTICID.BO has a market cap of 16.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while INSECTICID.BO trades at ₹581.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas INSECTICID.BO's P/E ratio is 12.98. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to INSECTICID.BO's ROE of +0.10%. Regarding short-term risk, ASTEC.BO is more volatile compared to INSECTICID.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check INSECTICID.BO's competition here
Insecticides (India) Limited (NSE: INSECTICID.NS)
ASTEC.BO vs INSECTICID.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, INSECTICID.NS has a market cap of 16.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while INSECTICID.NS trades at ₹581.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas INSECTICID.NS's P/E ratio is 13.01. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to INSECTICID.NS's ROE of +0.10%. Regarding short-term risk, ASTEC.BO is more volatile compared to INSECTICID.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check INSECTICID.NS's competition here
Astec LifeSciences Limited (NSE: ASTEC.NS)
ASTEC.BO vs ASTEC.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, ASTEC.NS has a market cap of 15.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while ASTEC.NS trades at ₹729.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas ASTEC.NS's P/E ratio is -23.75. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to ASTEC.NS's ROE of -0.17%. Regarding short-term risk, ASTEC.BO is less volatile compared to ASTEC.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check ASTEC.NS's competition here
India Pesticides Limited (NSE: IPL.NS)
ASTEC.BO vs IPL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, IPL.NS has a market cap of 15B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while IPL.NS trades at ₹128.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas IPL.NS's P/E ratio is 13.92. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to IPL.NS's ROE of +0.11%. Regarding short-term risk, ASTEC.BO is more volatile compared to IPL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check IPL.NS's competition here
India Pesticides Limited (BSE: IPL.BO)
ASTEC.BO vs IPL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, IPL.BO has a market cap of 14.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while IPL.BO trades at ₹129.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas IPL.BO's P/E ratio is 13.93. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to IPL.BO's ROE of +0.11%. Regarding short-term risk, ASTEC.BO is more volatile compared to IPL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check IPL.BO's competition here
Meghmani Organics Limited (BSE: MOL.BO)
ASTEC.BO vs MOL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MOL.BO has a market cap of 14.8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MOL.BO trades at ₹58.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MOL.BO's P/E ratio is 22.90. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MOL.BO's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to MOL.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check MOL.BO's competition here
Meghmani Organics Limited (NSE: MOL.NS)
ASTEC.BO vs MOL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MOL.NS has a market cap of 14.7B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MOL.NS trades at ₹58.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MOL.NS's P/E ratio is 22.85. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MOL.NS's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to MOL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check MOL.NS's competition here
Punjab Chemicals & Crop Protection Limited (NSE: PUNJABCHEM.NS)
ASTEC.BO vs PUNJABCHEM.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, PUNJABCHEM.NS has a market cap of 12.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while PUNJABCHEM.NS trades at ₹1,009.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas PUNJABCHEM.NS's P/E ratio is 19.67. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to PUNJABCHEM.NS's ROE of +0.16%. Regarding short-term risk, ASTEC.BO is less volatile compared to PUNJABCHEM.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check PUNJABCHEM.NS's competition here
Southern Petrochemical Industries Corporation Limited (NSE: SPIC.NS)
ASTEC.BO vs SPIC.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SPIC.NS has a market cap of 12.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SPIC.NS trades at ₹61.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SPIC.NS's P/E ratio is 5.94. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SPIC.NS's ROE of +0.15%. Regarding short-term risk, ASTEC.BO is more volatile compared to SPIC.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SPIC.NS's competition here
Southern Petrochemical Industries Corporation Limited (BSE: SPIC.BO)
ASTEC.BO vs SPIC.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SPIC.BO has a market cap of 12.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SPIC.BO trades at ₹61.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SPIC.BO's P/E ratio is 5.94. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SPIC.BO's ROE of +0.15%. Regarding short-term risk, ASTEC.BO is more volatile compared to SPIC.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SPIC.BO's competition here
Punjab Chemicals & Crop Protection Limited (BSE: PUNJABCHEM.BO)
ASTEC.BO vs PUNJABCHEM.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, PUNJABCHEM.BO has a market cap of 12.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while PUNJABCHEM.BO trades at ₹1,003.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas PUNJABCHEM.BO's P/E ratio is 19.50. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to PUNJABCHEM.BO's ROE of +0.16%. Regarding short-term risk, ASTEC.BO is more volatile compared to PUNJABCHEM.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check PUNJABCHEM.BO's competition here
Madras Fertilizers Limited (BSE: MADRASFERT.BO)
ASTEC.BO vs MADRASFERT.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MADRASFERT.BO has a market cap of 9.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MADRASFERT.BO trades at ₹57.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MADRASFERT.BO's P/E ratio is 11.56. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MADRASFERT.BO's ROE of +1.22%. Regarding short-term risk, ASTEC.BO is less volatile compared to MADRASFERT.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check MADRASFERT.BO's competition here
Madras Fertilizers Limited (NSE: MADRASFERT.NS)
ASTEC.BO vs MADRASFERT.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MADRASFERT.NS has a market cap of 9.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MADRASFERT.NS trades at ₹57.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MADRASFERT.NS's P/E ratio is 11.51. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MADRASFERT.NS's ROE of +1.22%. Regarding short-term risk, ASTEC.BO is more volatile compared to MADRASFERT.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check MADRASFERT.NS's competition here
Dharmaj Crop Guard Limited (NSE: DHARMAJ.NS)
ASTEC.BO vs DHARMAJ.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, DHARMAJ.NS has a market cap of 8.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while DHARMAJ.NS trades at ₹259.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas DHARMAJ.NS's P/E ratio is 14.78. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to DHARMAJ.NS's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to DHARMAJ.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check DHARMAJ.NS's competition here
Dharmaj Crop Guard Limited (BSE: DHARMAJ.BO)
ASTEC.BO vs DHARMAJ.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, DHARMAJ.BO has a market cap of 8.8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while DHARMAJ.BO trades at ₹261.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas DHARMAJ.BO's P/E ratio is 14.72. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to DHARMAJ.BO's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to DHARMAJ.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check DHARMAJ.BO's competition here
Zuari Agro Chemicals Limited (NSE: ZUARI.NS)
ASTEC.BO vs ZUARI.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, ZUARI.NS has a market cap of 8.8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while ZUARI.NS trades at ₹206.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas ZUARI.NS's P/E ratio is 0.95. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to ZUARI.NS's ROE of +0.41%. Regarding short-term risk, ASTEC.BO is more volatile compared to ZUARI.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check ZUARI.NS's competition here
Zuari Agro Chemicals Limited (BSE: ZUARI.BO)
ASTEC.BO vs ZUARI.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, ZUARI.BO has a market cap of 8.7B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while ZUARI.BO trades at ₹206.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas ZUARI.BO's P/E ratio is 0.95. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to ZUARI.BO's ROE of +0.41%. Regarding short-term risk, ASTEC.BO is more volatile compared to ZUARI.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check ZUARI.BO's competition here
Bombay Super Hybrid Seeds Limited (NSE: BSHSL.NS)
ASTEC.BO vs BSHSL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BSHSL.NS has a market cap of 8.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BSHSL.NS trades at ₹83.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BSHSL.NS's P/E ratio is 28.66. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BSHSL.NS's ROE of +0.23%. Regarding short-term risk, ASTEC.BO is less volatile compared to BSHSL.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check BSHSL.NS's competition here
Bharat Rasayan Limited (NSE: BHARATRAS.NS)
ASTEC.BO vs BHARATRAS.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BHARATRAS.NS has a market cap of 8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BHARATRAS.NS trades at ₹964.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BHARATRAS.NS's P/E ratio is 11.21. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BHARATRAS.NS's ROE of +0.12%. Regarding short-term risk, ASTEC.BO is more volatile compared to BHARATRAS.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BHARATRAS.NS's competition here
Bharat Rasayan Limited (BSE: BHARATRAS.BO)
ASTEC.BO vs BHARATRAS.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BHARATRAS.BO has a market cap of 8B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BHARATRAS.BO trades at ₹965.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BHARATRAS.BO's P/E ratio is 7.53. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BHARATRAS.BO's ROE of +0.12%. Regarding short-term risk, ASTEC.BO is more volatile compared to BHARATRAS.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BHARATRAS.BO's competition here
Heranba Industries Limited (NSE: HERANBA.NS)
ASTEC.BO vs HERANBA.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, HERANBA.NS has a market cap of 6.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while HERANBA.NS trades at ₹162.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas HERANBA.NS's P/E ratio is -8.60. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to HERANBA.NS's ROE of -0.09%. Regarding short-term risk, ASTEC.BO is more volatile compared to HERANBA.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check HERANBA.NS's competition here
Heranba Industries Limited (BSE: HERANBA.BO)
ASTEC.BO vs HERANBA.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, HERANBA.BO has a market cap of 6.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while HERANBA.BO trades at ₹161.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas HERANBA.BO's P/E ratio is -8.57. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to HERANBA.BO's ROE of -0.09%. Regarding short-term risk, ASTEC.BO is more volatile compared to HERANBA.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check HERANBA.BO's competition here
Aries Agro Limited (BSE: ARIES.BO)
ASTEC.BO vs ARIES.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, ARIES.BO has a market cap of 6.2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while ARIES.BO trades at ₹482.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas ARIES.BO's P/E ratio is 12.95. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to ARIES.BO's ROE of +0.15%. Regarding short-term risk, ASTEC.BO is more volatile compared to ARIES.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check ARIES.BO's competition here
Aries Agro Limited (NSE: ARIES.NS)
ASTEC.BO vs ARIES.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, ARIES.NS has a market cap of 6.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while ARIES.NS trades at ₹482.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas ARIES.NS's P/E ratio is 12.86. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to ARIES.NS's ROE of +0.15%. Regarding short-term risk, ASTEC.BO is more volatile compared to ARIES.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check ARIES.NS's competition here
Best Agrolife Limited (NSE: BESTAGRO.NS)
ASTEC.BO vs BESTAGRO.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BESTAGRO.NS has a market cap of 6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BESTAGRO.NS trades at ₹16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BESTAGRO.NS's P/E ratio is 20.08. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BESTAGRO.NS's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to BESTAGRO.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BESTAGRO.NS's competition here
Best Agrolife Limited (BSE: BESTAGRO.BO)
ASTEC.BO vs BESTAGRO.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BESTAGRO.BO has a market cap of 5.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BESTAGRO.BO trades at ₹16.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BESTAGRO.BO's P/E ratio is 20.10. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BESTAGRO.BO's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is more volatile compared to BESTAGRO.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BESTAGRO.BO's competition here
Shivalik Rasayan Limited (NSE: SHIVALIK.NS)
ASTEC.BO vs SHIVALIK.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SHIVALIK.NS has a market cap of 5.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SHIVALIK.NS trades at ₹349.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SHIVALIK.NS's P/E ratio is 41.50. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SHIVALIK.NS's ROE of +0.02%. Regarding short-term risk, ASTEC.BO is more volatile compared to SHIVALIK.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SHIVALIK.NS's competition here
Shivalik Rasayan Limited (BSE: SHIVALIK.BO)
ASTEC.BO vs SHIVALIK.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SHIVALIK.BO has a market cap of 5.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SHIVALIK.BO trades at ₹350.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SHIVALIK.BO's P/E ratio is 41.42. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SHIVALIK.BO's ROE of +0.02%. Regarding short-term risk, ASTEC.BO is more volatile compared to SHIVALIK.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check SHIVALIK.BO's competition here
Khaitan Chemicals and Fertilizers Limited (NSE: KHAICHEM.NS)
ASTEC.BO vs KHAICHEM.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, KHAICHEM.NS has a market cap of 4.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while KHAICHEM.NS trades at ₹48.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas KHAICHEM.NS's P/E ratio is 7.15. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to KHAICHEM.NS's ROE of +0.19%. Regarding short-term risk, ASTEC.BO is more volatile compared to KHAICHEM.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check KHAICHEM.NS's competition here
Khaitan Chemicals and Fertilizers Limited (BSE: KHAICHEM.BO)
ASTEC.BO vs KHAICHEM.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, KHAICHEM.BO has a market cap of 4.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while KHAICHEM.BO trades at ₹48.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas KHAICHEM.BO's P/E ratio is 7.12. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to KHAICHEM.BO's ROE of +0.19%. Regarding short-term risk, ASTEC.BO is more volatile compared to KHAICHEM.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check KHAICHEM.BO's competition here
Rama Phosphates Limited (BSE: RAMAPHO.BO)
ASTEC.BO vs RAMAPHO.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, RAMAPHO.BO has a market cap of 3.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while RAMAPHO.BO trades at ₹109.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas RAMAPHO.BO's P/E ratio is 7.39. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to RAMAPHO.BO's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to RAMAPHO.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check RAMAPHO.BO's competition here
Rama Phosphates Limited (NSE: RAMAPHO.NS)
ASTEC.BO vs RAMAPHO.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, RAMAPHO.NS has a market cap of 3.9B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while RAMAPHO.NS trades at ₹109.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas RAMAPHO.NS's P/E ratio is 7.39. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to RAMAPHO.NS's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to RAMAPHO.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check RAMAPHO.NS's competition here
Indogulf Cropsciences Ltd. (NSE: IGCL.NS)
ASTEC.BO vs IGCL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, IGCL.NS has a market cap of 3.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while IGCL.NS trades at ₹55.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas IGCL.NS's P/E ratio is 9.10. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to IGCL.NS's ROE of +0.09%. Regarding short-term risk, ASTEC.BO is more volatile compared to IGCL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check IGCL.NS's competition here
Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN.NS)
ASTEC.BO vs NATHBIOGEN.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NATHBIOGEN.NS has a market cap of 2.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NATHBIOGEN.NS trades at ₹137.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NATHBIOGEN.NS's P/E ratio is 6.82. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NATHBIOGEN.NS's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to NATHBIOGEN.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NATHBIOGEN.NS's competition here
Nath Bio-Genes (India) Limited (BSE: NATHBIOGEN.BO)
ASTEC.BO vs NATHBIOGEN.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NATHBIOGEN.BO has a market cap of 2.6B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NATHBIOGEN.BO trades at ₹137.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NATHBIOGEN.BO's P/E ratio is 6.79. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NATHBIOGEN.BO's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to NATHBIOGEN.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NATHBIOGEN.BO's competition here
Tierra Agrotech Limited (BSE: TIERRA.BO)
ASTEC.BO vs TIERRA.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, TIERRA.BO has a market cap of 2.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while TIERRA.BO trades at ₹36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas TIERRA.BO's P/E ratio is -33.62. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to TIERRA.BO's ROE of -0.07%. Regarding short-term risk, ASTEC.BO is more volatile compared to TIERRA.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check TIERRA.BO's competition here
Nova Agritech Limited (NSE: NOVAAGRI.NS)
ASTEC.BO vs NOVAAGRI.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NOVAAGRI.NS has a market cap of 2B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NOVAAGRI.NS trades at ₹21.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NOVAAGRI.NS's P/E ratio is 15.35. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NOVAAGRI.NS's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is less volatile compared to NOVAAGRI.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check NOVAAGRI.NS's competition here
Mangalam Seeds Limited (BSE: MSL.BO)
ASTEC.BO vs MSL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, MSL.BO has a market cap of 1.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while MSL.BO trades at ₹146.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas MSL.BO's P/E ratio is 18.00. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to MSL.BO's ROE of +0.09%. Regarding short-term risk, ASTEC.BO is less volatile compared to MSL.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check MSL.BO's competition here
Indo US Bio-Tech Limited (BSE: INDOUS.BO)
ASTEC.BO vs INDOUS.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, INDOUS.BO has a market cap of 1.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while INDOUS.BO trades at ₹73.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas INDOUS.BO's P/E ratio is 12.78. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to INDOUS.BO's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is more volatile compared to INDOUS.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check INDOUS.BO's competition here
Indo US Bio-Tech Limited (NSE: INDOUS.NS)
ASTEC.BO vs INDOUS.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, INDOUS.NS has a market cap of 1.5B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while INDOUS.NS trades at ₹73.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas INDOUS.NS's P/E ratio is 12.73. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to INDOUS.NS's ROE of +0.13%. Regarding short-term risk, ASTEC.BO is less volatile compared to INDOUS.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check INDOUS.NS's competition here
Sir Shadi Lal Enterprises Limited (BSE: SSLEL.BO)
ASTEC.BO vs SSLEL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SSLEL.BO has a market cap of 1.4B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SSLEL.BO trades at ₹263.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SSLEL.BO's P/E ratio is -5.77. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SSLEL.BO's ROE of +0.16%. Regarding short-term risk, ASTEC.BO is less volatile compared to SSLEL.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check SSLEL.BO's competition here
Sikko Industries Limited (NSE: SIKKO.NS)
ASTEC.BO vs SIKKO.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SIKKO.NS has a market cap of 1.3B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SIKKO.NS trades at ₹5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SIKKO.NS's P/E ratio is 43.39. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SIKKO.NS's ROE of +0.07%. Regarding short-term risk, ASTEC.BO is less volatile compared to SIKKO.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check SIKKO.NS's competition here
Bharat Agri Fert & Realty Ltd. (BSE: BHARATAGRI.BO)
ASTEC.BO vs BHARATAGRI.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BHARATAGRI.BO has a market cap of 1.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BHARATAGRI.BO trades at ₹21.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BHARATAGRI.BO's P/E ratio is -17.06. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BHARATAGRI.BO's ROE of -0.14%. Regarding short-term risk, ASTEC.BO is more volatile compared to BHARATAGRI.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BHARATAGRI.BO's competition here
ShreeOswal Seeds and Chemicals Limited (NSE: OSWALSEEDS.NS)
ASTEC.BO vs OSWALSEEDS.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, OSWALSEEDS.NS has a market cap of 1.1B. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while OSWALSEEDS.NS trades at ₹11.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas OSWALSEEDS.NS's P/E ratio is 8.92. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to OSWALSEEDS.NS's ROE of +0.25%. Regarding short-term risk, ASTEC.BO is less volatile compared to OSWALSEEDS.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check OSWALSEEDS.NS's competition here
Crop Life Science Ltd. (NSE: CLSL.NS)
ASTEC.BO vs CLSL.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, CLSL.NS has a market cap of 993.3M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while CLSL.NS trades at ₹56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas CLSL.NS's P/E ratio is 14.63. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to CLSL.NS's ROE of N/A. Regarding short-term risk, ASTEC.BO is more volatile compared to CLSL.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check CLSL.NS's competition here
Basant Agro Tech (India) Limited (BSE: BASANTGL.BO)
ASTEC.BO vs BASANTGL.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BASANTGL.BO has a market cap of 967.9M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BASANTGL.BO trades at ₹10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BASANTGL.BO's P/E ratio is 13.87. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BASANTGL.BO's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is less volatile compared to BASANTGL.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check BASANTGL.BO's competition here
Nagarjuna Fertilizers and Chemicals Limited (NSE: NAGAFERT.NS)
ASTEC.BO vs NAGAFERT.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NAGAFERT.NS has a market cap of 962.9M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NAGAFERT.NS trades at ₹1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NAGAFERT.NS's P/E ratio is -6.34. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NAGAFERT.NS's ROE of +0.02%. Regarding short-term risk, ASTEC.BO is less volatile compared to NAGAFERT.NS. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check NAGAFERT.NS's competition here
Nagarjuna Fertilizers and Chemicals Limited (BSE: NAGAFERT.BO)
ASTEC.BO vs NAGAFERT.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NAGAFERT.BO has a market cap of 960.2M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NAGAFERT.BO trades at ₹1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NAGAFERT.BO's P/E ratio is -6.71. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NAGAFERT.BO's ROE of +0.02%. Regarding short-term risk, ASTEC.BO is more volatile compared to NAGAFERT.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NAGAFERT.BO's competition here
Indra Industries Limited (BSE: INDRAIND.BO)
ASTEC.BO vs INDRAIND.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, INDRAIND.BO has a market cap of 907.3M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while INDRAIND.BO trades at ₹16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas INDRAIND.BO's P/E ratio is 74.91. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to INDRAIND.BO's ROE of -0.33%. Regarding short-term risk, ASTEC.BO is more volatile compared to INDRAIND.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check INDRAIND.BO's competition here
Narmada Agrobase Limited (BSE: NARMADA.BO)
ASTEC.BO vs NARMADA.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NARMADA.BO has a market cap of 847.1M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NARMADA.BO trades at ₹11.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NARMADA.BO's P/E ratio is 21.96. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NARMADA.BO's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is less volatile compared to NARMADA.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check NARMADA.BO's competition here
Narmada Agrobase Limited (NSE: NARMADA.NS)
ASTEC.BO vs NARMADA.NS Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, NARMADA.NS has a market cap of 846M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while NARMADA.NS trades at ₹11.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas NARMADA.NS's P/E ratio is 21.65. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to NARMADA.NS's ROE of +0.06%. Regarding short-term risk, ASTEC.BO is more volatile compared to NARMADA.NS. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check NARMADA.NS's competition here
Teesta Agro Industries Limited (BSE: TEEAI.BO)
ASTEC.BO vs TEEAI.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, TEEAI.BO has a market cap of 621.3M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while TEEAI.BO trades at ₹109.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas TEEAI.BO's P/E ratio is 7.46. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to TEEAI.BO's ROE of +0.07%. Regarding short-term risk, ASTEC.BO is more volatile compared to TEEAI.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check TEEAI.BO's competition here
Bhaskar Agrochemicals Limited (BSE: BHASKAGR.BO)
ASTEC.BO vs BHASKAGR.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, BHASKAGR.BO has a market cap of 528.5M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while BHASKAGR.BO trades at ₹105.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas BHASKAGR.BO's P/E ratio is 66.66. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to BHASKAGR.BO's ROE of +0.23%. Regarding short-term risk, ASTEC.BO is more volatile compared to BHASKAGR.BO. This indicates higher risk in terms of short-term price fluctuations for ASTEC.BO.Check BHASKAGR.BO's competition here
Kemistar Corporation Limited (BSE: KEMISTAR.BO)
ASTEC.BO vs KEMISTAR.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, KEMISTAR.BO has a market cap of 502.9M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while KEMISTAR.BO trades at ₹45.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas KEMISTAR.BO's P/E ratio is 0.12. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to KEMISTAR.BO's ROE of +0.04%. Regarding short-term risk, ASTEC.BO is less volatile compared to KEMISTAR.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check KEMISTAR.BO's competition here
Super Crop Safe Limited (BSE: SUCROSA.BO)
ASTEC.BO vs SUCROSA.BO Comparison October 2026
Astec LifeSciences Limited (BSE: ASTEC.BO) plays a significant role within the Basic Materials sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASTEC.BO stands at 15.8B. In comparison, SUCROSA.BO has a market cap of 496.3M. Regarding current trading prices, ASTEC.BO is priced at ₹730.90 on the BSE, while SUCROSA.BO trades at ₹13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASTEC.BO currently has a P/E ratio of -23.74, whereas SUCROSA.BO's P/E ratio is 32.33. In terms of profitability, ASTEC.BO's ROE is -0.17%, compared to SUCROSA.BO's ROE of +0.07%. Regarding short-term risk, ASTEC.BO is less volatile compared to SUCROSA.BO. This indicates lower risk in terms of short-term price fluctuations for ASTEC.BO.Check SUCROSA.BO's competition here